Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
158.02B
Market cap158.02B
Price-Earnings ratio
37.24
Price-Earnings ratio37.24
Dividend yield
6.12%
Dividend yield6.12%
Average volume
34.98M
Average volume34.98M
High today
$28.19
High today$28.19
Low today
$27.70
Low today$27.70
Open price
$28.15
Open price$28.15
Volume
7.97M
Volume7.97M
52 Week high
$29.21
52 Week high$29.21
52 Week low
$23.62
52 Week low$23.62

Stock Snapshot

As of today, Pfizer(PFE) shares are valued at $27.73. The company's market cap stands at 158.02B, with a P/E ratio of 37.24 and a dividend yield of 6.12%.

During the trading session on 2026-10-02, Pfizer(PFE) shares reached a daily high of $28.19 and a low of $27.70. At a current price of $27.73, the stock is +0.1% higher than the low and still -1.6% under the high.

Trading activity shows a volume of 7.97M, compared to an average daily volume of 34.98M.

The stock's 52-week range extends from a low of $23.62 to a high of $29.21.

The stock's 52-week range extends from a low of $23.62 to a high of $29.21.

PFE News

The Motley Fool 7h
Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.

If you've been looking for high-yield stocks, Pfizer (PFE -1.40%) may have crossed your radar screen. As shares of the pharma giant slipped over the past few ye...

Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.
The Motley Fool 17h
Kevin Warsh's Inflation Stance Makes These Cheap Dividend Stocks Look a Lot More Attractive

After 100 days at the head of the Federal Reserve, Kevin Warsh gave a speech outlining the economic situation. While employment has been stable, which is positi...

Kevin Warsh's Inflation Stance Makes These Cheap Dividend Stocks Look a Lot More Attractive
MarketWatch 19h
Pfizer Inc. stock outperforms competitors despite losses on the day - MarketWatch

...

Pfizer Inc. stock outperforms competitors despite losses on the day - MarketWatch

Analyst ratings

61%

of 28 ratings
Buy
32.1%
Hold
60.7%
Sell
7.1%

More PFE News

Benzinga 20h
Pfizer Says Eczema Drug Shows Significant Skin Clearance

Pfizer Inc. (NYSE:PFE) on Thursday presented detailed Phase 2 results for tilrekimig (PF-07275315) in adults with moderate-to-severe atopic dermatitis. The ong...

Pfizer Says Eczema Drug Shows Significant Skin Clearance
Simply Wall St 22h
Does Pfizer Have A New Growth Driver In Tilrekimig?

Pfizer (NYSE:PFE) reported Phase 2 data for tilrekimig, a trispecific antibody candidate, in moderate to severe atopic dermatitis. The study showed clinically...

Does Pfizer Have A New Growth Driver In Tilrekimig?
TipRanks 23h
Florida sues Pfizer over COVID vaccine marketing

Florida Attorney General James Uthmeier filed a lawsuit against Pfizer (PFE) and its CEO Dr. Albert Bourla. Uthmeier said via X: “Weeks ago we learned Fauci and...

24/7 Wall St. 1d
Treasury Yields Are Above 5%. These 4 Dividend Stocks Still Make the Cut

Investing Treasury Yields Are Above 5%. These 4 Dividend Stocks Still Make the Cut A 5% Treasury yield raises the bar for every dividend stock in a retirement p...

Treasury Yields Are Above 5%. These 4 Dividend Stocks Still Make the Cut
TipRanks 1d
Pfizer says Phase 2 study of tilrekimig met primary endpoint

Pfizer (PFE) presented detailed results from an ongoing Phase 2 study investigating tilrekimig in adults with moderate-to-severe atopic dermatitis. The study me...

Nasdaq 3d
With the Market Flashing Warning Signs Not Seen Since the Dot-Com Bust, Is Pfizer's 6% Yield a Safe Haven or a Trap?

Key Points Pfizer is facing several headwinds, which have weighed on its financial results. The company isn't currently generating enough cash to cover its hi...

With the Market Flashing Warning Signs Not Seen Since the Dot-Com Bust, Is Pfizer's 6% Yield a Safe Haven or a Trap?
Nasdaq 3d
PFE Dividend Yield Pushes Past 6%

Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of Pfizer Inc (Symbol: PFE) were yielding above the 6% mark based...

PFE Dividend Yield Pushes Past 6%

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.